Humedix Hosts 'Re2O Fine Launch Symposium' for Medical Professionals
Humedix, the aesthetics subsidiary of the Huons Group, held a symposium to commemorate the launch of its new 'Re2O' brand product and engaged in academic exchanges with medical professionals.
On the 24th, Humedix Co., Ltd. announced that it hosted a symposium celebrating the launch of 'Re2O Fine' for medical professionals at the Atlas Hall of The Westin Chosun Seoul Parnas in Gangnam-gu, Seoul.
On the 24th, Director Hansem Kim of Yongsan DOD Dermatology held the 'Re2O Fine Launch Symposium' at the Westin Seoul Parnas in Gangnam-gu, Seoul. Humedics
View original imageThe symposium was organized as an academic platform to introduce the new 'Re2O Fine' product under the 'Re2O' brand, the first ECM (extracellular matrix) booster in Korea to incorporate human acellular dermal matrix (hADM). Around 150 medical professionals specializing in dermatology and cosmetic surgery attended to share case studies and discuss the latest clinical insights.
The event began with opening remarks from Kang Minjong, CEO of Humedix, and Park Jeyoung, director of Oracle Dermatology Clinic in Apgujeong. This was followed by presentations from three speakers, each sharing their experiences and the characteristics and effects of 'Re2O Fine' in clinical practice.
The first lecture was given by Dr. Hansem Kim, director of Yongsan DOD Dermatology Clinic, who presented an overview of 'Re2O Fine', focusing on "New Periocular Skin Reconstruction Using Micro-Particles of Re2O Fine". Dr. Hansem Kim highlighted the unique advantages and mechanisms of 'Re2O Fine', emphasizing that despite the smaller particle size compared to the original Re2O, its effectiveness is maintained.
The second speaker, Dr. Park Jeyoung from Oracle Dermatology Clinic in Apgujeong, delivered a lecture on "Precise Periocular ECM Restoration Beyond Volumizing and Cell Stimulation with Re2O Fine". Dr. Park explained, "While previous procedures were limited to simple physical expansion or stimulation, Re2O Fine is differentiated in that it fundamentally reconstructs the dermal environment." He analyzed the mechanism, stating, "The hADM component acts precisely on the thinned dermal layer, enabling natural and high-quality restoration of the skin under the eyes."
The third lecture was presented by Dr. Lee Jungwoo, director of Cheongdam Elev Clinic, on the topic "Beyond Surface Improvement: Multilayered Restoration of Neck Wrinkles with Re2O Fine".
Dr. Lee shared, "The excellent skin regeneration effect of Re2O Fine is not limited to the periocular area," adding, "We confirmed its outstanding extensibility and elasticity improvement even for neck wrinkles, which are known to be challenging to treat," based on clinical cases.
Re2O is a human tissue-derived product that enhances safety by removing cellular and immune rejection factors while preserving the unique three-dimensional structure (scaffold) of the tissue. Building on its successful market introduction last year, Humedix has strengthened its product portfolio this year by launching Re2O Fine.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Kang Minjong, CEO of Humedix, stated, "This event was meaningful in proving the clinical value of Re2O Fine through the voices of medical professionals," adding, "We plan to solidify our position in the ECM market based on our diverse Re2O lineup."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.